Table 1.
Variant | Location | EA | OA | EAF | βGWAS | Gene | Expressiona | Distance to TSS | PeQTL | βeQTL |
---|---|---|---|---|---|---|---|---|---|---|
rs4683184 | chr3:46146215 | G | A | 0.37 | − 0.01 | CCR5 | 22.96 ± 7.33 | − 224,638 | 2.06E−04 | − 0.47 |
rs13072536 | chr3:52827195 | T | A | 0.22 | 0.02 | SFMBT1 | 2.87 ± 0.59 | − 219,556 | 1.43E−04 | 0.50 |
rs1991431 | chr3:141414608 | A | G | 0.44 | − 0.02 | ZBTB38 | 7.13 ± 1.57 | 90,395 | 7.68E−05 | 0.44 |
rs1550270 | chr4:165340648 | C | T | 0.33 | 0.02 | CPE | 4.64 ± 3.7 | − 20,546 | 7.29E−06 | 0.51 |
rs798545 | chr7:2722752 | T | C | 0.23 | 0.01 | GNA12 | 21.9 ± 4.75 | − 121,573 | 7.94E−05 | 0.53 |
rs2551769 | chr7:135453583 | A | G | 0.28 | 0.01 | CALD1 | 1.23 ± 1.05 | 709,328 | 1.38E−05 | − 0.58 |
rs11245388 | chr10:124850559 | T | G | 0.47 | − 0.01 | METTL10 | 1.06 ± 0.19 | 58,688 | 1.47E−11 | 0.72 |
rs3212240 | chr14:24341692 | C | T | 0.43 | − 0.01 | RIPK3 | 4.51 ± 1.07 | 1646 | 1.47E−06 | − 0.55 |
rs7147775 | chr14:75203508 | G | T | 0.44 | − 0.02 | EIF2B2 | 4.62 ± 0.58 | 200,597 | 2.16E−09 | − 0.62 |
rs7147775 | chr14:75203508 | G | T | 0.44 | − 0.02 | ACYP1 | 1.8 ± 0.56 | 134,024 | 4.75E−06 | 0.55 |
rs11073930 | chr15:90503480 | G | C | 0.46 | − 0.02 | IQGAP1 | 66.34 ± 9.26 | 115,262 | 1.46E−10 | 0.66 |
rs1736213 | chr17:17231214 | T | G | 0.43 | 0.01 | FLCN | 4.06 ± 0.89 | − 5975 | 1.82E−09 | − 0.54 |
rs1661725 | chr17:75564053 | C | T | 0.44 | 0.01 | LLGL2 | 0.7 ± 0.24 | 38,973 | 9.98E−07 | − 0.55 |
rs77420750 | chr19:15868934 | A | C | 0.31 | 0.01 | TMEM38A | 0.49 ± 0.29 | − 792,194 | 1.43E−04 | 0.45 |
rs314675 | chr19:46692822 | C | T | 0.1 | − 0.02 | FKRP | 1.45 ± 0.27 | − 53,224 | 5.88E−06 | 0.92 |
rs73066226 | chr19:58496846 | C | T | 0.17 | 0.01 | UBE2M | 22.85 ± 3.39 | − 62,115 | 1.71E−06 | 0.66 |
rs5754387 | chr22:21620414 | C | G | 0.17 | − 0.02 | UBE2L3 | 20.1 ± 2.88 | 70,967 | 1.82E−05 | 0.46 |
rs2294358 | chr22:36375211 | C | G | 0.07 | 0.04 | FOXRED2 | 2.44 ± 1.37 | − 131,893 | 1.55E−06 | 1.11 |
rs932536 | chr22:49866824 | A | G | 0.13 | − 0.02 | ZBED4 | 5.67 ± 0.67 | 12,982 | 8.39E−06 | 0.71 |
rs5770908 | chr22:50439289 | A | G | 0.29 | − 0.02 | PPP6R2 | 10.17 ± 1.8 | 95,985 | 1.36E−04 | 0.41 |
rs5914035 | chrX:56981783 | C | T | 0.23 | 0.02 | LINC01420 | 13.14 ± 2.09 | 252,542 | 4.91E−06 | 0.62 |
EA effect allele, OA other allele, EAF effect allele frequency (derived from the osteoclast eQTL cohort), eBMD estimated BMD, TSS transcription start site; variant locations derived from dbSNP build 150 (GRCh38/hg38), βGWAS values are relevant to the effect allele and were obtained from Morris et al. [19], βeQTL values are given as the normalised effect size on gene expression for the effect allele. eQTL associations are significant using a multiple-testing corrected FDR of 5%
aExpression levels are stated as mean reads per kilobase million (RPKM) ± standard deviation